A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD

from HCPLive Podcasts · host HCPLive.com

Dr. Lally of New England Retina Consultants joins to discuss avacincaptad pegol, a promising injection treatment for GA, and its supporting data from the GATHER trial program. Will the complement C5 inhibitor drug receive FDA approval in 2023? Lally discusses this and more on the latest DocTalk.

Episode metadata supplied by the publisher feed · Published Nov 10, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD

0:00 18:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HCPLive Podcasts?

This episode is 18 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on November 10, 2022.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!